SlideShare a Scribd company logo
1 of 5
Erik Blixt
Computational Prediction of Vaccine Strains for Human Influenza A (H3N2) Virus
Introduction
Influenzapandemicshave causedover50milliondeathsworldwide,withanaverage of 23
thousanddeathsperyearin the UnitedStates(1).Althoughavaccine is available, itonlyprotectsthe
recipientfromthree of fourstrainsof the virus.The strainschosenforthe vaccine are selectedafter
fromresearchof predominate strainsfromthe previousseason.
The Influenzavirus isinthe familyof Orthomyxovirus, meaningthatithas a negative senseRNA
genome with6-8linearsegmentsof RNA.Eachof these RNAsencode specificproteinsneededforthe
virus’slife cycle(2).Glycoproteinsonthe influenzavirus’ssurface bindtospecificreceptorson the
surface of the targetcell andis endocytosedintothe cell.The viral RNP segmentsare releasedfrom
capsidinthe nucleusthen broughtintothe nucleustobe splicedtogetherintomRNA segments.These
mRNA segmentsare localized intothe cytoplasmtobe translated intoearly viral proteinswhichencode
the viral surface glycoproteinsandproteinstoencode late genesforviral genomereplication.Once the
viral RNA has been replicated intoaviral genome RNA transcriptthe virus andenclosedby
nucleocapsids,the virusisreleasedfromthe cell throughexocytosis.Asthe virusexitsthe cell,the
envelopeof the hostcell becomesthe envelope of the virus,withthe viral glycoproteinsonthe surface.
The capsid glycoproteinshemagglutininandneuraminidase(HA andNA,respectively) are used
to bindselectivelybindandtargetspecificregionsof the host’scell membraneforentry(3).Genetic
changesinthe sequence of glycoproteinsleads toantigenicdifferences.Asaresult,HA and NA are
groupedintodifferentsubtypes. HA isgroupedintosubtypes1-18 andNA intosubtypes1-11,and
variouscombinationof these twosubtypescanoccur inthe viral genome.
If a hostis infectedwithmultiple strainsof the virus,withdifferingglycoproteinsubtypes,the
opportunityforantigenicshiftoccurs.Twoor more differentstrainsof the same viruscombine toforma
newsubtype bymixingsurface antigensof the original strains.Forexample if ahostcell wasinfected
withbothH1N1 and H3N2 subtypes,the resultingprogenycouldbe anycombinationof those subtypes
(H1N1, H1N2, H3N1, or H3N2).
The varyingspecificallelicsequencesof eachof the glycoproteinRNA segments increases
geneticdiversitywithinthe population. Antigenicshiftincreasesthe difficultyof accuratelyestablishing
a vaccine.Because of this,the WorldHealthOrganization(WHO) collectsandevaluatesdatatopredict
whichstrainsof the viruswill be mostprevalentinthe subsequentseasonsothatan effective vaccine
can be developed.
In thispaper,researchersfromthe Steinbrücklabinthe HeinrichHeineUniversity inDüsseldorf,
Germanyproposeda methodtoovercome the challengeof selectingstrainstouse.Theyhypothesized
that if theycoulddevelopacomputational method forselectingthe circulatingpredominantand
emergingstrainsof InfluenzaA fromthe previousyears’data,thenthisinformationcanbe usedto
Erik Blixt
predictwhichstrainsof the vaccinesshouldbe usedfora seasonal fluvaccine. Thispaperwasof interest
to me because,asan applicantto the epidemiologyprogram, thispaperpotentiallypresentsanew,and
more accurate, processforselectingwhichstrainsof the fluvaccine touse eachseason.
ResultsandDiscussion
The German teamsoughtto determine whichstrainsof the viruswouldachieve dominance
each seasonbyquantifyingthe numberof infectionsof eachstrainof the virus,andcomparingthese
resultstopreviousyearstodetermine the rate of increase foreachstrain.These datawouldshowwhich
of the strainshada specificgeneticadvantage andcouldbe targetedbya vaccine before anendemic
occurred. Data on the strainswere obtainedfromthe InfluenzaViral Resourse,usingsamplesfrom
1995-2007(35).
Steinbrück’steamdevelopedamethodtobetterdetermine whichstrainsshouldbe produced
for a seasonal InfluenzaA (H3N2) virusvaccine.Theywere able todetermine whichunique HA alleles
were onthe rise tofuture predominance usinginformationgatheredfrompreviousseasons,using4
methodsystem.First,theydevelopedaphylogenetictree of the variousstrainsof the H3N2 virusandits
serotypes.Second,anADplotwasdevelopedfromthistree todeterminewhich3strainsof the virus
were mostlikelytobecome dominantinfuture seasons.Third,anantigenictree wasdevelopedfrom
the phylogenetictree andHIdistanceswere usedtoidentifythe antigenicvarietyof the 3most
prevalentHA alleles.Finally,aunique HA allelewasdeterminedtobecome dominantif ithadan
antigenicweightof .5antigenicunitsorgreater,indicatinganincrease of frequencyof 5%.If these
alleleswerenotpredominantinthe populationbefore(x>50% of the population),thenthe allelewould
be proposedtobe addedtothe nextseason’svaccine.
To determine the differencesof eachof the viral strains,a hemaglutinininhibitionassay(HI) is
performedeachyearon humansera from a sample of the population(4).Thisassaydeterminesthe
phenotypicpropertiesof eachstrainbycomparingthe antigenicsimilaritiesbetweentwostrainsof the
virusbasedonthe agglutinationof redbloodcells.FromthisdataSmithetal developedan“antigenic
cartography” to visualizedatafromHI anddetermine antigenicdifferences(5).Thisinformation wasalso
usedincombinationwithallele dynamicsplots(AD),whichwereusedtoindicate whichweremost
affectedbydirectional selection,andthuscorrelatedtothe virus’sdominance inapopulation(6).The
allelicfrequencywasdeterminedbythe numberof isolateswiththatalleleonaspecificphylogenetic
branch compared, tothe entire populationof thatseason.
The German teamusedthisinformationtodevelopan“antigenictree”,whichmapped antigenic
differencesin aphylogenetictree(7).Thismethodusedantigenicdistancestoestablishantigenic
weights,whichcouldthenbe usedtodetermine setsof codingchangesinHA. Steinbrückusedthis
information, alongwiththe ADplotstoidentifyantigenicallydistinctallelesof HA,andcorrelatedthis
data withthe emergence of dominant viral strains.
Erik Blixt
Thisdata demonstratedhowtheywere able topredictwhichviral strainswouldhave the
greatestpredominanceinapopulation.Theirstudieswere basedondatafrom2002 – 2007, and only
usedsamplesfrom2 yearsprecedingthe seasonof thatyear.Theirdata wasusedto determine which
strainsfor a vaccine wouldhave beenmosteffective,andcomparedtheirresultstothatof the WHO’s
InfluenzaSurveillance andResponse System.
Theirdata were used todetermine whichvaccine wouldhave beenmosteffective forthe
previous seasoninquestion andcomparedwiththe datacollectedfromWHO.A vaccine update would
have beenrecommendedif anovel strainwaspredictedpositivetobecome predominantinthe
subsequentseason,basedonif the allelehadanantigenicimpactgreaterthan.5 antigenicunits,the
amountfor one antigentobindto a target receptor.Theirresultswere categorizedinto4categories
whencomparedwiththe WHO’sdata. True positives(positive allelesthatwere accuratelypredicted
positive),true negatives(negative allelesthatwere accuratelypredictednegative),falsepositives
(negative allelesthatwere incorrectlypredictedpositive),andfalse negatives(positive allelesthatwere
incorrectlypredictednegative).A false positiveresultwouldhave beenmostdetrimental asthe vaccine
wouldhave beenincorrectlyupdated,replacingatrulypositivestrainwiththe false positive.
In the 2003 seasonto the 2004-2005 season,FU02 strainwaspredominantwithHA allele coding
changesat 156H, 75Q, and 155T(8). The allele wasrankedfirstforthe 2002-2003 season,andwas
predictedasa true positive candidate forthe vaccine strain.The WHOalsorecommendedthe FU02
strainin thatsame year.FU02 was replacedbyCA04 inthe 2004-2005 season,withHA allele changesat
145N, 159F, and 226I, andrankedfirstinthe AD plotinthe 2005 season,one yearafter
predominance(9).Thisallelewasgivenafalse negativereport,butthisisdue to the fact that samples
were notobtainedinthe 2004-2005 season,a yearbefore itspredominance.The WHOincludedCA04in
theirvaccine 2 seasonstoolate,generatingafalse positive aswell. Inthe 2006 seasonWI05 replaced
CA04 as the dominantstrainwithHA allele changesin193F,and correctlypredictedasa true
positive(10).The allele alsorankedveryhighlyinthe 2006-2007 season,butwas notre predictedforthe
vaccine as itwas alreadyselectedinthe seasonbefore.The WHOonlyaddedWI05 inthe 2006-2007
season,makingita false negative forthem.Finally,BR07became predominantinthe 2007 seasonwith
HA allelicchangesin50E and 140I(11). Itwas noticedinthe 2006-2007 seasonbutonlyhad a small 4%
increase inthe AD plot,therefore itwasnotrecommendedforthe vaccine inthe 2007 season,nor2007-
2008. Boththe Germanteamand WHO failedtorecognize these falsenegatives.Thisisprobablydue to
the fact that the strain appearedverylate inthe 2006-2007 season,aftermostsampleswere
concluded(12).Everyothertestresultedinatrue negative for Steinbrück’steam.
Withthe exceptionof the false positive in2004 withFU02 and the false negative withBR07in
2007, Steinbrück’steamaccuratelypredictedthe toprankedallelesfromthe ADplot25/27 times,with
93% accuracy. Whenseasonswere scoredasto predictthe mostpopularstrainof the season,
Steinbrück’steamscored78%accuracy. In comparison,the WHO onlyscoredwith66% accuracy(6).
Erik Blixt
The group accuratelypredictedthe 3most prevalentstrainof InfluenzaA with12% higher
accuracy thenthe WHO. By usinga combinationof ADplotsandantigenictreestocompare the
antigenicweightof strains;the emergence of strainswere accuratelypredictedayearin advance, only
usingdata fromthe previous2 seasons. Anyerrorin theirfindingwouldbe largelydue to factorsoutof
theircontrol.Forexample, the group’sonlyfalsepositivewas due toa lack of available datafromthat
season.Thisproblemiseasilyrectifiedasmore datais available andbetterrecordkeepinghas
developedastime progresses.
Thispaperillustrateshowlarge scale computeranalysiscanaiddramaticallyinepidemiological
research. Steinbrück’steamprocessedinformationbetweentwodatasets, usingADplotsto identifyHA
alleleswiththe largestincrease inprevalence andantigenictreestodetermine the antigenicimpactof
those results, toaccuratelypredictthe effectsof antigenicdrift.But Steinbrück’steamisnotthe only
groupto attemptto innovate hownewmodelscanbe usedtopredictthe flu’sspread. Łuksza& Lässigat
the Universityof Columbiacreatedafitnessfunctionthatpredictedthe growthrate of viral strains
basedon a susceptible-infected-recovered(SIR)modelandantigenchangestomeasure pathogen-host-
interaction(13).Inanotherresearchstudy, Duetal usedHIanalysistodetermine asequence of
antigenicsimilarityof viral strains(14).
Steinbrück’spapershowsthe beginningof anew periodof epidemiological dataprocessingin
the computerage.For a nextexperiment,if theseapproachesweretobe combinedwith othernew
methodsfrom Łuksza& Lässig’slab or Dr. Du’s lab andcomparedthe accuracy to the current WHO
model,thenthiscouldleadtoa dramaticrevolutioninhow aide isable tobe providedworldwide.
Steinbrück’smethodhasbeentested,andresultedinahigheraccuracythan the current model used.
These methodsshouldbe appliedbythe WHOas part of the standardpredictionprocess.
References
1) Tognotti E. 2009. Influenzapandemics:ahistorical retrospect.J.Infect. Dev.Ctries. 3:331–334.
http://dx.doi.org/10.3855/jidc.239.
2) FouchierRAM, Munster V,WallenstenA,BestebroerTM, Herfst S, SmithD, RimmelzwaanGF,
OlsenB, Osterhaus ADME. 2005. Characterization of anovel influenzaA virushemagglutinin
subtype (H16) obtained fromblack-headedgulls.J.Virol. 79:2814–2822. http://dx.doi.org
/10.1128/JVI.79.5.2814-2822.2005
3) Tong S, Zhu X, Li Y,Shi M, Zhang J, Bourgeois M,Yang H, ChenX, Recuenco S, GomezJ,Chen
LM, Johnson A, Tao Y, DreyfusC, Yu W, McBride R, CarneyPJ, GilbertAT, Chang J, GuoZ, Davis
CT, Paulson JC,StevensJ, Rupprecht CE, HolmesEC, WilsonIA, DonisRO. 2013. New worldbats
harbor diverse influenzaA viruses.PLoSPathog. 9:e1003657.
http://dx.doi.org/10.1371/journal.ppat.1003657.
Erik Blixt
4) Hirst GK. 1943. Studiesof antigenicdifferencesamongstrainsof influenzaA bymeansof red cell
agglutination.J.Exp.Med. 78:407–423. http://dx.doi.org/10.1084/jem.78.5.407.
5) Smith DJ, LapedesAS, de Jong JC,BestebroerTM, RimmelzwaanGF, OsterhausADME,
FouchierRAM. 2004. Mappingthe antigenicandgeneticevolutionof influenzavirus.Science
305:371–376. http://dx.doi.org/10.1126/science.1097211.
6) SteinbrückL, McHardy AC. 2011. Allele dynamicsplotsforthe studyof evolutionarydynamicsin
viral populations.NucleicAcidsRes. 39:e4. http://dx.doi.org/10.1093/nar/gkq909.
7) Bao Y,Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, Tatusova T, Ostell J,Lipman D. 2008. The
influenzavirusresource atthe National CenterforBiotechnologyInformation.J.Virol. 82:596–
601. http://dx.doi.org/10.1128/JVI.02005-07.
8) WHO. 2003. Recommendedcompositionof influenzavirusvaccinesforuse inthe 2004 influenza
season.Wkly.Epidemiol.Rec. 78:375–379.
9) WHO. 2005. Recommendedcompositionof influenzavirusvaccinesforuse inthe 2005-2006
influenzaseason.Wkly.Epidemiol.Rec. 80: 66 –71.
10) WHO. 2006. Recommendedcompositionof influenzavirusvaccinesforuse inthe 2006-2007
influenzaseason.Wkly.Epidemiol.Rec. 81:82–86.
11) WHO. 2007. Recommendedcompositionof influenzavirusvaccinesforuse inthe 2008 influenza
season.Wkly.Epidemiol.Rec. 82:351–356.
12) WHO. 2007. Recommendedcompositionof influenzavirusvaccinesforuse inthe 2007-2008
influenzaseason.Wkly.Epidemiol.Rec. 82:69–74.
13) Łuksza M,Lässig M. 2014. A predictive fitnessmodel forinfluenza.Nature 507:57–61.
http://dx.doi.org/10.1038/nature13087.
14) Du X, Dong L, Lan Y, PengY, WuA, Zhang Y, Huang W,Wang D, Wang M, GuoY, Shu Y, JiangT.
2012. Mappingof H3N2 influenzaantigenicevolutioninChinarevealsastrategyforvaccine
strainrecommendation.Nat.Commun. 3:709. http://dx.doi.org/10.1038/ncomms1710.

More Related Content

What's hot

Les dossiers d’expertise du Dr Hervé Seligmann, du Prof. Luc Montagnier et du...
Les dossiers d’expertise du Dr Hervé Seligmann, du Prof. Luc Montagnier et du...Les dossiers d’expertise du Dr Hervé Seligmann, du Prof. Luc Montagnier et du...
Les dossiers d’expertise du Dr Hervé Seligmann, du Prof. Luc Montagnier et du...Guy Boulianne
 
The Vaccine Death Report
The Vaccine Death ReportThe Vaccine Death Report
The Vaccine Death ReportGuy Boulianne
 
ImmunoScience Introduction
ImmunoScience IntroductionImmunoScience Introduction
ImmunoScience Introductioncosmicuno
 
An integrated genomic surveillance platform reveals multiple introductions an...
An integrated genomic surveillance platform reveals multiple introductions an...An integrated genomic surveillance platform reveals multiple introductions an...
An integrated genomic surveillance platform reveals multiple introductions an...Data Con LA
 
Sars cov 2 spike mutations paper los alamos
Sars cov 2 spike mutations paper los alamosSars cov 2 spike mutations paper los alamos
Sars cov 2 spike mutations paper los alamosJauru Freitas
 
Alexander Gold - CAEV Literature Review for Industry
Alexander Gold - CAEV Literature Review for IndustryAlexander Gold - CAEV Literature Review for Industry
Alexander Gold - CAEV Literature Review for IndustryAlexander Gold
 
Development of diagnostic tools to reduce antimicrobial (mis)use: Novel ident...
Development of diagnostic tools to reduce antimicrobial (mis)use: Novel ident...Development of diagnostic tools to reduce antimicrobial (mis)use: Novel ident...
Development of diagnostic tools to reduce antimicrobial (mis)use: Novel ident...ILRI
 
J. Virol.-2012-Qureshi-2239-50
J. Virol.-2012-Qureshi-2239-50J. Virol.-2012-Qureshi-2239-50
J. Virol.-2012-Qureshi-2239-50Huma Qureshi
 
vaccine development against malaria parasite
vaccine development against malaria parasitevaccine development against malaria parasite
vaccine development against malaria parasiteswarnendu basak
 
New developments in vaccines against African swine fever
New developments in vaccines against African swine feverNew developments in vaccines against African swine fever
New developments in vaccines against African swine feverILRI
 
Genomic surveillance of the Rift Valley fever: From sequencing to Lineage ass...
Genomic surveillance of the Rift Valley fever: From sequencing to Lineage ass...Genomic surveillance of the Rift Valley fever: From sequencing to Lineage ass...
Genomic surveillance of the Rift Valley fever: From sequencing to Lineage ass...ILRI
 
Recent advances in African swine fever vaccine development at the Internation...
Recent advances in African swine fever vaccine development at the Internation...Recent advances in African swine fever vaccine development at the Internation...
Recent advances in African swine fever vaccine development at the Internation...ILRI
 
Malaria Vaccine Development: A Step Towards Reality
Malaria Vaccine Development: A Step Towards RealityMalaria Vaccine Development: A Step Towards Reality
Malaria Vaccine Development: A Step Towards RealityDr Muktikesh Dash, MD, PGDFM
 
Malaria vaccine presentation
Malaria vaccine presentationMalaria vaccine presentation
Malaria vaccine presentationdeluxe1234
 
Exploring the origin and potential for spread of the 2013 dengue outbreak in ...
Exploring the origin and potential for spread of the 2013 dengue outbreak in ...Exploring the origin and potential for spread of the 2013 dengue outbreak in ...
Exploring the origin and potential for spread of the 2013 dengue outbreak in ...Yan'an Hou
 

What's hot (20)

Les dossiers d’expertise du Dr Hervé Seligmann, du Prof. Luc Montagnier et du...
Les dossiers d’expertise du Dr Hervé Seligmann, du Prof. Luc Montagnier et du...Les dossiers d’expertise du Dr Hervé Seligmann, du Prof. Luc Montagnier et du...
Les dossiers d’expertise du Dr Hervé Seligmann, du Prof. Luc Montagnier et du...
 
The Vaccine Death Report
The Vaccine Death ReportThe Vaccine Death Report
The Vaccine Death Report
 
ImmunoScience Introduction
ImmunoScience IntroductionImmunoScience Introduction
ImmunoScience Introduction
 
An integrated genomic surveillance platform reveals multiple introductions an...
An integrated genomic surveillance platform reveals multiple introductions an...An integrated genomic surveillance platform reveals multiple introductions an...
An integrated genomic surveillance platform reveals multiple introductions an...
 
Sars cov 2 spike mutations paper los alamos
Sars cov 2 spike mutations paper los alamosSars cov 2 spike mutations paper los alamos
Sars cov 2 spike mutations paper los alamos
 
Alexander Gold - CAEV Literature Review for Industry
Alexander Gold - CAEV Literature Review for IndustryAlexander Gold - CAEV Literature Review for Industry
Alexander Gold - CAEV Literature Review for Industry
 
Development of diagnostic tools to reduce antimicrobial (mis)use: Novel ident...
Development of diagnostic tools to reduce antimicrobial (mis)use: Novel ident...Development of diagnostic tools to reduce antimicrobial (mis)use: Novel ident...
Development of diagnostic tools to reduce antimicrobial (mis)use: Novel ident...
 
J. Virol.-2012-Qureshi-2239-50
J. Virol.-2012-Qureshi-2239-50J. Virol.-2012-Qureshi-2239-50
J. Virol.-2012-Qureshi-2239-50
 
Corona virus stats
Corona virus statsCorona virus stats
Corona virus stats
 
vaccine development against malaria parasite
vaccine development against malaria parasitevaccine development against malaria parasite
vaccine development against malaria parasite
 
New developments in vaccines against African swine fever
New developments in vaccines against African swine feverNew developments in vaccines against African swine fever
New developments in vaccines against African swine fever
 
Genomic surveillance of the Rift Valley fever: From sequencing to Lineage ass...
Genomic surveillance of the Rift Valley fever: From sequencing to Lineage ass...Genomic surveillance of the Rift Valley fever: From sequencing to Lineage ass...
Genomic surveillance of the Rift Valley fever: From sequencing to Lineage ass...
 
Recent advances in African swine fever vaccine development at the Internation...
Recent advances in African swine fever vaccine development at the Internation...Recent advances in African swine fever vaccine development at the Internation...
Recent advances in African swine fever vaccine development at the Internation...
 
The world of coronaviruses
The world of coronavirusesThe world of coronaviruses
The world of coronaviruses
 
9 Malaria Vaccine (1)
9 Malaria Vaccine (1)9 Malaria Vaccine (1)
9 Malaria Vaccine (1)
 
Malaria Vaccine Development: A Step Towards Reality
Malaria Vaccine Development: A Step Towards RealityMalaria Vaccine Development: A Step Towards Reality
Malaria Vaccine Development: A Step Towards Reality
 
Postdoc day 2010
Postdoc day 2010Postdoc day 2010
Postdoc day 2010
 
Hiv
HivHiv
Hiv
 
Malaria vaccine presentation
Malaria vaccine presentationMalaria vaccine presentation
Malaria vaccine presentation
 
Exploring the origin and potential for spread of the 2013 dengue outbreak in ...
Exploring the origin and potential for spread of the 2013 dengue outbreak in ...Exploring the origin and potential for spread of the 2013 dengue outbreak in ...
Exploring the origin and potential for spread of the 2013 dengue outbreak in ...
 

Viewers also liked

Les adolescents et les médias sociaux: une collaboration informelle pour un ...
Les adolescents et les médias sociaux: une collaboration informelle pour un ...Les adolescents et les médias sociaux: une collaboration informelle pour un ...
Les adolescents et les médias sociaux: une collaboration informelle pour un ...Nadia Naffi, Ph.D.
 
Rocksminerals 121114154111-phpapp01
Rocksminerals 121114154111-phpapp01Rocksminerals 121114154111-phpapp01
Rocksminerals 121114154111-phpapp01riddhimaapril
 
Chapter 15 Buku Implementing Continuous Quality Improvement in Health care
Chapter 15 Buku Implementing Continuous Quality Improvement in Health careChapter 15 Buku Implementing Continuous Quality Improvement in Health care
Chapter 15 Buku Implementing Continuous Quality Improvement in Health careNasiatul Salim
 
Derecho internacional privado ninfa zapata
Derecho internacional privado ninfa zapataDerecho internacional privado ninfa zapata
Derecho internacional privado ninfa zapataNinfa Zapata Vergara
 
Naffi_Nadia_2012_Learning to Exist in Social Media- A grounded Theory About ...
Naffi_Nadia_2012_Learning to Exist in Social Media-  A grounded Theory About ...Naffi_Nadia_2012_Learning to Exist in Social Media-  A grounded Theory About ...
Naffi_Nadia_2012_Learning to Exist in Social Media- A grounded Theory About ...Nadia Naffi, Ph.D.
 
Mihai_Tache_Detailed_CV_v10
Mihai_Tache_Detailed_CV_v10Mihai_Tache_Detailed_CV_v10
Mihai_Tache_Detailed_CV_v10Mihai Tache
 
Chapter 7 Buku The Health care Quality Book
Chapter 7 Buku The Health care Quality BookChapter 7 Buku The Health care Quality Book
Chapter 7 Buku The Health care Quality BookNasiatul Salim
 
Chapter 16 Buku The Health care Quality Book
Chapter 16 Buku The Health care Quality BookChapter 16 Buku The Health care Quality Book
Chapter 16 Buku The Health care Quality BookNasiatul Salim
 
Označení provozovny
Označení provozovny Označení provozovny
Označení provozovny Firmin
 
Maxine McKew: still hopin' for the right education solution
Maxine McKew: still hopin' for the right education solutionMaxine McKew: still hopin' for the right education solution
Maxine McKew: still hopin' for the right education solutionokraradar11
 

Viewers also liked (16)

Les adolescents et les médias sociaux: une collaboration informelle pour un ...
Les adolescents et les médias sociaux: une collaboration informelle pour un ...Les adolescents et les médias sociaux: une collaboration informelle pour un ...
Les adolescents et les médias sociaux: une collaboration informelle pour un ...
 
Mohammed Abdulelah Saleh
Mohammed Abdulelah SalehMohammed Abdulelah Saleh
Mohammed Abdulelah Saleh
 
Rocksminerals 121114154111-phpapp01
Rocksminerals 121114154111-phpapp01Rocksminerals 121114154111-phpapp01
Rocksminerals 121114154111-phpapp01
 
Chapter 15 Buku Implementing Continuous Quality Improvement in Health care
Chapter 15 Buku Implementing Continuous Quality Improvement in Health careChapter 15 Buku Implementing Continuous Quality Improvement in Health care
Chapter 15 Buku Implementing Continuous Quality Improvement in Health care
 
Derecho internacional privado ninfa zapata
Derecho internacional privado ninfa zapataDerecho internacional privado ninfa zapata
Derecho internacional privado ninfa zapata
 
CADCAM
CADCAMCADCAM
CADCAM
 
Naffi_Nadia_2012_Learning to Exist in Social Media- A grounded Theory About ...
Naffi_Nadia_2012_Learning to Exist in Social Media-  A grounded Theory About ...Naffi_Nadia_2012_Learning to Exist in Social Media-  A grounded Theory About ...
Naffi_Nadia_2012_Learning to Exist in Social Media- A grounded Theory About ...
 
Mihai_Tache_Detailed_CV_v10
Mihai_Tache_Detailed_CV_v10Mihai_Tache_Detailed_CV_v10
Mihai_Tache_Detailed_CV_v10
 
Chapter 7 Buku The Health care Quality Book
Chapter 7 Buku The Health care Quality BookChapter 7 Buku The Health care Quality Book
Chapter 7 Buku The Health care Quality Book
 
watermarking
watermarkingwatermarking
watermarking
 
.
..
.
 
Chapter 16 Buku The Health care Quality Book
Chapter 16 Buku The Health care Quality BookChapter 16 Buku The Health care Quality Book
Chapter 16 Buku The Health care Quality Book
 
Filming schedule2
Filming schedule2Filming schedule2
Filming schedule2
 
Gosia Furmanik CV
Gosia Furmanik CVGosia Furmanik CV
Gosia Furmanik CV
 
Označení provozovny
Označení provozovny Označení provozovny
Označení provozovny
 
Maxine McKew: still hopin' for the right education solution
Maxine McKew: still hopin' for the right education solutionMaxine McKew: still hopin' for the right education solution
Maxine McKew: still hopin' for the right education solution
 

Similar to Computational Prediction of Vaccine Strains for Human Influenza A

Replication Competent IAV and IBV with Timer Article.PDF
Replication Competent IAV and IBV with Timer Article.PDFReplication Competent IAV and IBV with Timer Article.PDF
Replication Competent IAV and IBV with Timer Article.PDFMichael Breen
 
Seasonal influeza vaccine 2018
Seasonal influeza vaccine 2018Seasonal influeza vaccine 2018
Seasonal influeza vaccine 2018Ashraf ElAdawy
 
COVID-19 Project.pdf
COVID-19 Project.pdfCOVID-19 Project.pdf
COVID-19 Project.pdfAdeel224241
 
Influenza secrets do you know
Influenza secrets do you knowInfluenza secrets do you know
Influenza secrets do you knowMohamed Alashram
 
Influenza a h1 ni latest
Influenza a h1 ni latestInfluenza a h1 ni latest
Influenza a h1 ni latestBea Galang
 
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...Álvaro L. Valiñas
 
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...Álvaro L. Valiñas
 
influenzapresentation
influenzapresentationinfluenzapresentation
influenzapresentationguest66dc5f
 
Frontier virology_review_Oh et al 2016
Frontier virology_review_Oh et al 2016Frontier virology_review_Oh et al 2016
Frontier virology_review_Oh et al 2016Ding Y Oh
 

Similar to Computational Prediction of Vaccine Strains for Human Influenza A (20)

Influenza vaccines
Influenza vaccinesInfluenza vaccines
Influenza vaccines
 
Replication Competent IAV and IBV with Timer Article.PDF
Replication Competent IAV and IBV with Timer Article.PDFReplication Competent IAV and IBV with Timer Article.PDF
Replication Competent IAV and IBV with Timer Article.PDF
 
AbbasMorovvati
AbbasMorovvatiAbbasMorovvati
AbbasMorovvati
 
Seasonal influeza vaccine 2018
Seasonal influeza vaccine 2018Seasonal influeza vaccine 2018
Seasonal influeza vaccine 2018
 
Swine flu
Swine flu Swine flu
Swine flu
 
COVID-19 Project.pdf
COVID-19 Project.pdfCOVID-19 Project.pdf
COVID-19 Project.pdf
 
M Ezzat El Zowalaty EUSOM
M Ezzat El Zowalaty EUSOMM Ezzat El Zowalaty EUSOM
M Ezzat El Zowalaty EUSOM
 
Dr. Obumneke Amadi-Onuoha Scripts-29
Dr. Obumneke Amadi-Onuoha Scripts-29Dr. Obumneke Amadi-Onuoha Scripts-29
Dr. Obumneke Amadi-Onuoha Scripts-29
 
Chen 2008
Chen 2008Chen 2008
Chen 2008
 
11 influenzae virus
11 influenzae virus11 influenzae virus
11 influenzae virus
 
3_1_1_JVR
3_1_1_JVR3_1_1_JVR
3_1_1_JVR
 
Influenza secrets do you know
Influenza secrets do you knowInfluenza secrets do you know
Influenza secrets do you know
 
Influenza a h1 ni latest
Influenza a h1 ni latestInfluenza a h1 ni latest
Influenza a h1 ni latest
 
Lary nel abao genetic engineering final report
Lary nel abao genetic engineering final reportLary nel abao genetic engineering final report
Lary nel abao genetic engineering final report
 
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...
 
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...
 
influenzapresentation
influenzapresentationinfluenzapresentation
influenzapresentation
 
elife-83470-v1.pdf
elife-83470-v1.pdfelife-83470-v1.pdf
elife-83470-v1.pdf
 
Frontier virology_review_Oh et al 2016
Frontier virology_review_Oh et al 2016Frontier virology_review_Oh et al 2016
Frontier virology_review_Oh et al 2016
 
The Yan Report
The Yan ReportThe Yan Report
The Yan Report
 

Computational Prediction of Vaccine Strains for Human Influenza A

  • 1. Erik Blixt Computational Prediction of Vaccine Strains for Human Influenza A (H3N2) Virus Introduction Influenzapandemicshave causedover50milliondeathsworldwide,withanaverage of 23 thousanddeathsperyearin the UnitedStates(1).Althoughavaccine is available, itonlyprotectsthe recipientfromthree of fourstrainsof the virus.The strainschosenforthe vaccine are selectedafter fromresearchof predominate strainsfromthe previousseason. The Influenzavirus isinthe familyof Orthomyxovirus, meaningthatithas a negative senseRNA genome with6-8linearsegmentsof RNA.Eachof these RNAsencode specificproteinsneededforthe virus’slife cycle(2).Glycoproteinsonthe influenzavirus’ssurface bindtospecificreceptorson the surface of the targetcell andis endocytosedintothe cell.The viral RNP segmentsare releasedfrom capsidinthe nucleusthen broughtintothe nucleustobe splicedtogetherintomRNA segments.These mRNA segmentsare localized intothe cytoplasmtobe translated intoearly viral proteinswhichencode the viral surface glycoproteinsandproteinstoencode late genesforviral genomereplication.Once the viral RNA has been replicated intoaviral genome RNA transcriptthe virus andenclosedby nucleocapsids,the virusisreleasedfromthe cell throughexocytosis.Asthe virusexitsthe cell,the envelopeof the hostcell becomesthe envelope of the virus,withthe viral glycoproteinsonthe surface. The capsid glycoproteinshemagglutininandneuraminidase(HA andNA,respectively) are used to bindselectivelybindandtargetspecificregionsof the host’scell membraneforentry(3).Genetic changesinthe sequence of glycoproteinsleads toantigenicdifferences.Asaresult,HA and NA are groupedintodifferentsubtypes. HA isgroupedintosubtypes1-18 andNA intosubtypes1-11,and variouscombinationof these twosubtypescanoccur inthe viral genome. If a hostis infectedwithmultiple strainsof the virus,withdifferingglycoproteinsubtypes,the opportunityforantigenicshiftoccurs.Twoor more differentstrainsof the same viruscombine toforma newsubtype bymixingsurface antigensof the original strains.Forexample if ahostcell wasinfected withbothH1N1 and H3N2 subtypes,the resultingprogenycouldbe anycombinationof those subtypes (H1N1, H1N2, H3N1, or H3N2). The varyingspecificallelicsequencesof eachof the glycoproteinRNA segments increases geneticdiversitywithinthe population. Antigenicshiftincreasesthe difficultyof accuratelyestablishing a vaccine.Because of this,the WorldHealthOrganization(WHO) collectsandevaluatesdatatopredict whichstrainsof the viruswill be mostprevalentinthe subsequentseasonsothatan effective vaccine can be developed. In thispaper,researchersfromthe Steinbrücklabinthe HeinrichHeineUniversity inDüsseldorf, Germanyproposeda methodtoovercome the challengeof selectingstrainstouse.Theyhypothesized that if theycoulddevelopacomputational method forselectingthe circulatingpredominantand emergingstrainsof InfluenzaA fromthe previousyears’data,thenthisinformationcanbe usedto
  • 2. Erik Blixt predictwhichstrainsof the vaccinesshouldbe usedfora seasonal fluvaccine. Thispaperwasof interest to me because,asan applicantto the epidemiologyprogram, thispaperpotentiallypresentsanew,and more accurate, processforselectingwhichstrainsof the fluvaccine touse eachseason. ResultsandDiscussion The German teamsoughtto determine whichstrainsof the viruswouldachieve dominance each seasonbyquantifyingthe numberof infectionsof eachstrainof the virus,andcomparingthese resultstopreviousyearstodetermine the rate of increase foreachstrain.These datawouldshowwhich of the strainshada specificgeneticadvantage andcouldbe targetedbya vaccine before anendemic occurred. Data on the strainswere obtainedfromthe InfluenzaViral Resourse,usingsamplesfrom 1995-2007(35). Steinbrück’steamdevelopedamethodtobetterdetermine whichstrainsshouldbe produced for a seasonal InfluenzaA (H3N2) virusvaccine.Theywere able todetermine whichunique HA alleles were onthe rise tofuture predominance usinginformationgatheredfrompreviousseasons,using4 methodsystem.First,theydevelopedaphylogenetictree of the variousstrainsof the H3N2 virusandits serotypes.Second,anADplotwasdevelopedfromthistree todeterminewhich3strainsof the virus were mostlikelytobecome dominantinfuture seasons.Third,anantigenictree wasdevelopedfrom the phylogenetictree andHIdistanceswere usedtoidentifythe antigenicvarietyof the 3most prevalentHA alleles.Finally,aunique HA allelewasdeterminedtobecome dominantif ithadan antigenicweightof .5antigenicunitsorgreater,indicatinganincrease of frequencyof 5%.If these alleleswerenotpredominantinthe populationbefore(x>50% of the population),thenthe allelewould be proposedtobe addedtothe nextseason’svaccine. To determine the differencesof eachof the viral strains,a hemaglutinininhibitionassay(HI) is performedeachyearon humansera from a sample of the population(4).Thisassaydeterminesthe phenotypicpropertiesof eachstrainbycomparingthe antigenicsimilaritiesbetweentwostrainsof the virusbasedonthe agglutinationof redbloodcells.FromthisdataSmithetal developedan“antigenic cartography” to visualizedatafromHI anddetermine antigenicdifferences(5).Thisinformation wasalso usedincombinationwithallele dynamicsplots(AD),whichwereusedtoindicate whichweremost affectedbydirectional selection,andthuscorrelatedtothe virus’sdominance inapopulation(6).The allelicfrequencywasdeterminedbythe numberof isolateswiththatalleleonaspecificphylogenetic branch compared, tothe entire populationof thatseason. The German teamusedthisinformationtodevelopan“antigenictree”,whichmapped antigenic differencesin aphylogenetictree(7).Thismethodusedantigenicdistancestoestablishantigenic weights,whichcouldthenbe usedtodetermine setsof codingchangesinHA. Steinbrückusedthis information, alongwiththe ADplotstoidentifyantigenicallydistinctallelesof HA,andcorrelatedthis data withthe emergence of dominant viral strains.
  • 3. Erik Blixt Thisdata demonstratedhowtheywere able topredictwhichviral strainswouldhave the greatestpredominanceinapopulation.Theirstudieswere basedondatafrom2002 – 2007, and only usedsamplesfrom2 yearsprecedingthe seasonof thatyear.Theirdata wasusedto determine which strainsfor a vaccine wouldhave beenmosteffective,andcomparedtheirresultstothatof the WHO’s InfluenzaSurveillance andResponse System. Theirdata were used todetermine whichvaccine wouldhave beenmosteffective forthe previous seasoninquestion andcomparedwiththe datacollectedfromWHO.A vaccine update would have beenrecommendedif anovel strainwaspredictedpositivetobecome predominantinthe subsequentseason,basedonif the allelehadanantigenicimpactgreaterthan.5 antigenicunits,the amountfor one antigentobindto a target receptor.Theirresultswere categorizedinto4categories whencomparedwiththe WHO’sdata. True positives(positive allelesthatwere accuratelypredicted positive),true negatives(negative allelesthatwere accuratelypredictednegative),falsepositives (negative allelesthatwere incorrectlypredictedpositive),andfalse negatives(positive allelesthatwere incorrectlypredictednegative).A false positiveresultwouldhave beenmostdetrimental asthe vaccine wouldhave beenincorrectlyupdated,replacingatrulypositivestrainwiththe false positive. In the 2003 seasonto the 2004-2005 season,FU02 strainwaspredominantwithHA allele coding changesat 156H, 75Q, and 155T(8). The allele wasrankedfirstforthe 2002-2003 season,andwas predictedasa true positive candidate forthe vaccine strain.The WHOalsorecommendedthe FU02 strainin thatsame year.FU02 was replacedbyCA04 inthe 2004-2005 season,withHA allele changesat 145N, 159F, and 226I, andrankedfirstinthe AD plotinthe 2005 season,one yearafter predominance(9).Thisallelewasgivenafalse negativereport,butthisisdue to the fact that samples were notobtainedinthe 2004-2005 season,a yearbefore itspredominance.The WHOincludedCA04in theirvaccine 2 seasonstoolate,generatingafalse positive aswell. Inthe 2006 seasonWI05 replaced CA04 as the dominantstrainwithHA allele changesin193F,and correctlypredictedasa true positive(10).The allele alsorankedveryhighlyinthe 2006-2007 season,butwas notre predictedforthe vaccine as itwas alreadyselectedinthe seasonbefore.The WHOonlyaddedWI05 inthe 2006-2007 season,makingita false negative forthem.Finally,BR07became predominantinthe 2007 seasonwith HA allelicchangesin50E and 140I(11). Itwas noticedinthe 2006-2007 seasonbutonlyhad a small 4% increase inthe AD plot,therefore itwasnotrecommendedforthe vaccine inthe 2007 season,nor2007- 2008. Boththe Germanteamand WHO failedtorecognize these falsenegatives.Thisisprobablydue to the fact that the strain appearedverylate inthe 2006-2007 season,aftermostsampleswere concluded(12).Everyothertestresultedinatrue negative for Steinbrück’steam. Withthe exceptionof the false positive in2004 withFU02 and the false negative withBR07in 2007, Steinbrück’steamaccuratelypredictedthe toprankedallelesfromthe ADplot25/27 times,with 93% accuracy. Whenseasonswere scoredasto predictthe mostpopularstrainof the season, Steinbrück’steamscored78%accuracy. In comparison,the WHO onlyscoredwith66% accuracy(6).
  • 4. Erik Blixt The group accuratelypredictedthe 3most prevalentstrainof InfluenzaA with12% higher accuracy thenthe WHO. By usinga combinationof ADplotsandantigenictreestocompare the antigenicweightof strains;the emergence of strainswere accuratelypredictedayearin advance, only usingdata fromthe previous2 seasons. Anyerrorin theirfindingwouldbe largelydue to factorsoutof theircontrol.Forexample, the group’sonlyfalsepositivewas due toa lack of available datafromthat season.Thisproblemiseasilyrectifiedasmore datais available andbetterrecordkeepinghas developedastime progresses. Thispaperillustrateshowlarge scale computeranalysiscanaiddramaticallyinepidemiological research. Steinbrück’steamprocessedinformationbetweentwodatasets, usingADplotsto identifyHA alleleswiththe largestincrease inprevalence andantigenictreestodetermine the antigenicimpactof those results, toaccuratelypredictthe effectsof antigenicdrift.But Steinbrück’steamisnotthe only groupto attemptto innovate hownewmodelscanbe usedtopredictthe flu’sspread. Łuksza& Lässigat the Universityof Columbiacreatedafitnessfunctionthatpredictedthe growthrate of viral strains basedon a susceptible-infected-recovered(SIR)modelandantigenchangestomeasure pathogen-host- interaction(13).Inanotherresearchstudy, Duetal usedHIanalysistodetermine asequence of antigenicsimilarityof viral strains(14). Steinbrück’spapershowsthe beginningof anew periodof epidemiological dataprocessingin the computerage.For a nextexperiment,if theseapproachesweretobe combinedwith othernew methodsfrom Łuksza& Lässig’slab or Dr. Du’s lab andcomparedthe accuracy to the current WHO model,thenthiscouldleadtoa dramaticrevolutioninhow aide isable tobe providedworldwide. Steinbrück’smethodhasbeentested,andresultedinahigheraccuracythan the current model used. These methodsshouldbe appliedbythe WHOas part of the standardpredictionprocess. References 1) Tognotti E. 2009. Influenzapandemics:ahistorical retrospect.J.Infect. Dev.Ctries. 3:331–334. http://dx.doi.org/10.3855/jidc.239. 2) FouchierRAM, Munster V,WallenstenA,BestebroerTM, Herfst S, SmithD, RimmelzwaanGF, OlsenB, Osterhaus ADME. 2005. Characterization of anovel influenzaA virushemagglutinin subtype (H16) obtained fromblack-headedgulls.J.Virol. 79:2814–2822. http://dx.doi.org /10.1128/JVI.79.5.2814-2822.2005 3) Tong S, Zhu X, Li Y,Shi M, Zhang J, Bourgeois M,Yang H, ChenX, Recuenco S, GomezJ,Chen LM, Johnson A, Tao Y, DreyfusC, Yu W, McBride R, CarneyPJ, GilbertAT, Chang J, GuoZ, Davis CT, Paulson JC,StevensJ, Rupprecht CE, HolmesEC, WilsonIA, DonisRO. 2013. New worldbats harbor diverse influenzaA viruses.PLoSPathog. 9:e1003657. http://dx.doi.org/10.1371/journal.ppat.1003657.
  • 5. Erik Blixt 4) Hirst GK. 1943. Studiesof antigenicdifferencesamongstrainsof influenzaA bymeansof red cell agglutination.J.Exp.Med. 78:407–423. http://dx.doi.org/10.1084/jem.78.5.407. 5) Smith DJ, LapedesAS, de Jong JC,BestebroerTM, RimmelzwaanGF, OsterhausADME, FouchierRAM. 2004. Mappingthe antigenicandgeneticevolutionof influenzavirus.Science 305:371–376. http://dx.doi.org/10.1126/science.1097211. 6) SteinbrückL, McHardy AC. 2011. Allele dynamicsplotsforthe studyof evolutionarydynamicsin viral populations.NucleicAcidsRes. 39:e4. http://dx.doi.org/10.1093/nar/gkq909. 7) Bao Y,Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, Tatusova T, Ostell J,Lipman D. 2008. The influenzavirusresource atthe National CenterforBiotechnologyInformation.J.Virol. 82:596– 601. http://dx.doi.org/10.1128/JVI.02005-07. 8) WHO. 2003. Recommendedcompositionof influenzavirusvaccinesforuse inthe 2004 influenza season.Wkly.Epidemiol.Rec. 78:375–379. 9) WHO. 2005. Recommendedcompositionof influenzavirusvaccinesforuse inthe 2005-2006 influenzaseason.Wkly.Epidemiol.Rec. 80: 66 –71. 10) WHO. 2006. Recommendedcompositionof influenzavirusvaccinesforuse inthe 2006-2007 influenzaseason.Wkly.Epidemiol.Rec. 81:82–86. 11) WHO. 2007. Recommendedcompositionof influenzavirusvaccinesforuse inthe 2008 influenza season.Wkly.Epidemiol.Rec. 82:351–356. 12) WHO. 2007. Recommendedcompositionof influenzavirusvaccinesforuse inthe 2007-2008 influenzaseason.Wkly.Epidemiol.Rec. 82:69–74. 13) Łuksza M,Lässig M. 2014. A predictive fitnessmodel forinfluenza.Nature 507:57–61. http://dx.doi.org/10.1038/nature13087. 14) Du X, Dong L, Lan Y, PengY, WuA, Zhang Y, Huang W,Wang D, Wang M, GuoY, Shu Y, JiangT. 2012. Mappingof H3N2 influenzaantigenicevolutioninChinarevealsastrategyforvaccine strainrecommendation.Nat.Commun. 3:709. http://dx.doi.org/10.1038/ncomms1710.